View Cart
My AccountInfectious Disease Diagnostic Solutions
Microbix Phone+1803294983432Microbix Emailcustomer.service@microbix.com
Microbix Logo
Request Catalogue Contact Us
  • Services
    • Assay Development Solutions
    • Custom Vial Filling Services
  • Products
    • Reference Materials (QUANTDx™)
    • Antigens
      • All Antigens
      • Childhood Disease Antigens
      • Dengue Antigens
      • STI Antigens
      • ToRCH Antigens
      • Respiratory Antigens
      • Other Antigens
    • External Quality Controls (QAPs™)
      • All External QC Products
      • Respiratory Viral Panel
      • STI Panel
      • HPV Panel
      • Gastrointestinal Panel
      • Genital Ulcer Panel
      • Vaginal Infections Panel
      • ONBOARDx Kits
      • Proficiency Testing Panel
      • Technical Resources
    • DxTM™ Viral Transport Medium
    • Control Elution Buffer
    • Kinlytic (Urokinase)
  • About
    • Who We Are
    • Who We Work With
    • Quality
    • Board of Directors
    • Our Senior Team
    • Careers
  • Resources
    • Catalogues & Brochures
    • White Papers
    • Poster Publication
    • Podcasts
  • Investors
    • News Releases
    • Financial Reports
    • Corporate Presentations
    • Analyst Coverage
    • Corporate Governance
    • Stock Information
Contact Us
Microbix – KRC Insights FQ1 2026 Update

Microbix – KRC Insights FQ1 2026 Update

by Scott Patchanon | Feb 20, 2026 | Blog, Media Features News Releases, News Releases

Subject line: Microbix – KRC Insights FQ1 2026 Update   KRC Insights published an update report on Microbix’s FQ1 2026 financial results. All of KRC’s previous research reports, including this latest one, can be found on Microbix’s website here:...
Microbix Reports Results for Q1 2026

Microbix Reports Results for Q1 2026

by Shitika Kulshreshtha | Feb 12, 2026 | Blog, Media Features News Releases, News Releases

Q1 Revenues of $4.2 million and Controlled Net Loss   MISSISSAUGA, CANADA, February 12, 2026 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its first quarter of...
Microbix Welcomes The College of American Pathologists as a Client

Microbix Welcomes The College of American Pathologists as a Client

by Scott Patchanon | Feb 10, 2026 | Blog, News Releases

For Supply of QAPs for PT/EQA Programs   MISSISSAUGA, CANADA, February 10, 2026 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, is pleased to welcome the College of America Pathologists...
Microbix Schedules Release of Results for Q1 Fiscal 2026

Microbix Schedules Release of Results for Q1 Fiscal 2026

by Scott Patchanon | Feb 5, 2026 | Blog, News Releases

Results Release and Webinar Discussion on Morning of February 12, 2026   MISSISSAUGA, CANADA, February 5, 2026 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it expects...
Microbix Presents Molecular Pathology Platform Results

Microbix Presents Molecular Pathology Platform Results

by Scott Patchanon | Feb 4, 2026 | Blog, News Releases

Novel Quality Controls to Enable QC & Inter-Laboratory Standardization   MISSISSAUGA, CANADA, February 4, 2026 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is...
Microbix Updates Investor Presentation on its Website

Microbix Updates Investor Presentation on its Website

by Shitika Kulshreshtha | Jan 9, 2026 | Blog, News Releases

In Response to OSC Requirements to Explain EBITDA (a non-IFRS measure)   MISSISSAUGA, CANADA, January 9, 2026 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it has...
« Older Entries
  • Investors
  • Legal
  • Contact
  • News Releases
  • Accessibility
  • Careers
Microbix Funded By
Lab Image Lab Image

Get the Latest from Microbix—Straight to Your Inbox!

Stay up to date with news releases, product updates, tradeshows and conference information, and newsletters.


    Maybe later, science waits for no one